Cargando…

OR16-01 A Common WNT4 Polymorphism Drives Gynecologic Cancer Phenotypes And Health Disparities

Disclosure: B.G. Bitler: None. M.T. Shackleford: None. L.S. Treviño: None. L.S. Cook: None. M.J. Sikora: None. Gynecologic cancers such as ovarian cancer (OvCa) are among the deadliest affecting women due to therapy resistance and limited understanding of disease etiology and risk. An underexplored...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bitler, Benjamin G, Shackleford, Madeleine T, Treviño, Lindsey S, Cook, Linda S, Sikora, Matthew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554698/ http://dx.doi.org/10.1210/jendso/bvad114.2193

Ejemplares similares

THU552 Understanding Radiation Therapy Sensitivity In Invasive Lobular Carcinoma Of The Breast
por: Boysen, Michael Rhinehart, et al.
Publicado: (2023)

Wnt Signaling in Gynecologic Malignancies
por: McMellen, Alexandra, et al.
Publicado: (2020)

Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer: A cohort study based on 8,507 patients
por: Dybvik, Eva, et al.
Publicado: (2014)

EMBR-16. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA
por: Daggubati, Vikas, et al.
Publicado: (2021)

THU486 Identification Of Metabolic And Molecular Mechanisms Driving Estrogen Receptor Positive Breast Cancer Disparities Using A Machine-Learning Pipeline
por: Casiano, Ashlie Santaliz, et al.
Publicado: (2023)

OR16-2 Steroid Receptor Co-Activator Complexes Regulate Metabolic PFKFB Enzymes to Drive Therapy Resistant ER+ Breast Cancer
por: Benner, Elizabeth, et al.
Publicado: (2022)

Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics
por: Ade, Catherine M, et al.
Publicado: (2023)

EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA
por: Valinciute, Gintvile, et al.
Publicado: (2021)

EMBR-17. DE-INTENSIFICATION OF RADIOTHERAPY IN RIGOROUSLY DEFINED LOW-RISK WNT-SUBGROUP MEDULLOBLASTOMA IS ASSOCIATED WITH UNACCEPTABLY HIGH RISK OF NEURAXIAL FAILURE: RESULTS FROM THE PROSPECTIVE FOR-WNT STUDY
por: Gupta, Tejpal, et al.
Publicado: (2021)

Race, Insurance, and Sex-Based Disparities in Access to High-Volume Centers for Pancreatectomy
por: Williamson, Catherine G., et al.
Publicado: (2023)

Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study
por: Sutton, Thomas L., et al.
Publicado: (2021)

Stress-Induced Differential miR-4633-5p Expression in Thyroid Cancer Health Disparities
por: Mancao, Jonathan, et al.
Publicado: (2021)

Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis
por: Aquina, Christopher T., et al.
Publicado: (2022)

OR05-01 Small Heterodimer Partner Modulates Antigen Presenting Myeloid Cells to Impair Regulatory T Cell Expansion, Promoting Anti-Tumor Immunity in Models of Breast Cancer
por: Shahoei, Sayyed Hamed, et al.
Publicado: (2020)

Disparities in Gynecological Malignancies
por: Chatterjee, Sudeshna, et al.
Publicado: (2016)

OR05-01 Myeloid Cell Intrinsic NR0B2 Inhibits Regulatory T Cell Expansion Within The Tumor Microenvironment: Potential Novel Strategy For Breast Cancer Immunotherapy
por: Vidana Gamage, Hashni Epa, et al.
Publicado: (2023)

RARE-01. MANAGEMENT AND OUTCOMES OF PAEDIATRIC CRANIOPHARYNGIOMA: A 15-YEAR EXPERIENCE IN SINGAPORE
por: Lim, Mervyn Jun Rui, et al.
Publicado: (2020)

RARE-01. ASSESSING THE SYMPTOM DIAGNOSTIC INTERVAL FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMOURS
por: Crowell, Cameron, et al.
Publicado: (2021)

RARE-01. Cerebral infarction in childhood-onset craniopharyngioma patients: results of KRANIOPHARYNGEOM 2007
por: Boekhoff, Svenja, et al.
Publicado: (2022)

EMBR-20. ELONGATION CONTROL OF MRNA TRANSLATION DRIVES GROUP 3 MEDULLOBLASTOMA
por: Delaidelli, Alberto, et al.
Publicado: (2021)

OR16-04 Androgen Deprivation Restricts Anti-tumor Immunity In Adrenocortical Carcinoma
por: Warde, Kate M, et al.
Publicado: (2023)

Nuclear ErbB-2-Induced Transcriptome Drives Triple Negative Breast Cancer Growth
por: Chervo, Maria F, et al.
Publicado: (2021)

LBODP067 Primary Amenorrhea - A Common Referral With An Uncommon Cause
por: Shaikh, Sheeba, et al.
Publicado: (2022)

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2022)

OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis
por: Etella, Abora, et al.
Publicado: (2023)

OR16-02 Histone ADP-Ribosylation Site Mutations As Oncogenic Drivers In Breast And Ovarian Cancers
por: Huang, Dan, et al.
Publicado: (2023)

Steroid Receptor Co-Activators Regulate Metabolic Kinases to Drive Therapy Resistant ER+ Breast Cancer
por: Truong, Thu Ha, et al.
Publicado: (2021)

THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
por: Ufondu, Chinasa, et al.
Publicado: (2023)

Estrogen Regulation of mTOR Signaling and Mitochondrial Function in Invasive Lobular Carcinoma Cell Lines Requires WNT4
por: Shackleford, Madeleine T., et al.
Publicado: (2020)

MON-314 Insulin-like Growth Factor 2 Drives Hepatocellular Carcinoma In Hepatocyte Srsf3 Ko Mice
por: Kumar, Deepak, et al.
Publicado: (2019)

Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
por: Schoenfeld, A.J., et al.
Publicado: (2019)

PSUN375 What Blindness and Paraganglioma Have in Common? A Rare Case of Paraganglioma Syndrome
por: Esaki, Yumiko, et al.
Publicado: (2022)

PITUITARY TUMORS-01 HYPERPROLACTINEMIA AS A CLINICAL MARKER OF INVASIVE PROLACTINOMAS
por: Gankpe, Gbetoho Fortune, et al.
Publicado: (2023)

OR16-03 Epigenetic Studies Of Pancreatic Neuroendocrine Tumours (PNETs) Reveal Decreased DNA Hydroxymethylation In Non-functioning PNETs But Not Insulinomas
por: English, Katherine A, et al.
Publicado: (2023)

OR16-06 A Novel Pathway Controlling Anticancer Drug Induced Immunogenic Necrosis In ERα Positive Cancer Cells
por: Zhu, Junyao, et al.
Publicado: (2023)

GERM-01. RECURRENCE PATTERN AND SURVIVAL FOR RELAPSED INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS: A SINGLE-INSTITUTION EXPERIENCE
por: Wen, Lei
Publicado: (2021)

OR34-3 The Androgen Receptor Malignancy Shift Can Be Caused by Mutations Commonly Found in Primary Prostate Cancer
por: Copeland, Ben, et al.
Publicado: (2019)

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

SUN-336 Autocrine / Paracrine Growth Hormone (GH) Drives Multimodal Therapy Resistance in Growth Hormone Receptor (GHR)-expressing Human Cancers
por: Basu, Reetobrata, et al.
Publicado: (2019)

OR16-1 How Strong and Sustained Activation of the Estrogen Receptor-mediated Anticipatory Unfolded Protein Response Kills Breast and Ovarian Cancer Cells
por: Boudreau, Matthew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6qecghf9o15mg955fmild9v60s